• 1
    American Academy of Pediatrics. Committee on School Health. Guidelines for urgent care in school. Pediatrics 1990;86:9991000.
  • 2
    International Collaborative Study of Severe Anaphylaxis. An epidemiologic study of severe anaphylactic and anaphylactoid reactions among hospital patients: methods and overall risks. Epidemiology 1998;9:141146.
  • 3
    Australasian Society of Clinical Immunology and Allergy Inc. (ASCIA). Guidelines for EpiPen prescription. ASCIA Anaphylaxis Working Party 2004. Available online at Last accessed 20 September 2012.
  • 4
    Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; and Joint Council of Allergy, Asthma, and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 2005; 115(3 suppl): S483S523.
  • 5
    Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF, Bock A, Branum A et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006;117:391397.
  • 6
    Lieberman P, Camargo CA, Bohlke K, Jick H, Miller RL, Sheikh A et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol 2006;97:596602.
  • 7
    Simons FE, Sheikh A. Evidence-based management of anaphylaxis. Allergy 2007;62:827829.
  • 8
    Last JM, editor. A dictionary of epidemiology. 4th ed. New York, NY: Oxford University Press, 2000.
  • 9
    Simons FE, Sheikh A. Anaphylaxis: the acute episode and beyond. BMJ 2013;346:f602.
  • 10
    Panesar SS, Nwaru BI, Hickstein L, Rader T, Hamadah H, Ali DF et al. , European Academy of Allergy and Clinical Immunology Food Allergy and Anaphylaxis Guidelines group. The epidemiology of anaphylaxis in Europe: protocol for a systematic review. Clin Transl Allergy 2013; 3:9.
  • 11
    OCEBM Levels of Evidence Working Group. ‘The Oxford 2011 Levels of Evidence’. Oxford Centre for Evidence-Based Medicine. Available online at = 5653. Last accessed 28 September 2012.
  • 12
    CASP checklist for systematic reviews. Last accessed 10 October 2012.
  • 13
    CASP checklist for cohort studies. Last accessed 10 October 2012.
  • 14
    CASP checklist for case-control studies. Last accessed 10 October 2012.
  • 15
    Appraisal Tools Last accessed 20 September 2012.
  • 16
    Effective Public Health Practice Project Quality Assessment Tool. Last accessed 10 October 2012.
  • 17
    Agresti A, Coull BA. Approximate is better than ‘exact’ for interval estimation of binomial proportions. Am Statis 1998;52:119126.
  • 18
    Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA Statement. PLoS Med 6:e1000097.
  • 19
    Alvarado MI, Perez M. Study of food allergy in the Spanish population. Allergol Immunopathol 2006;34:185193.
  • 20
    Asero R, Antonicelli L, Arena A, Bommarito L, Caruso B, Colombo G et al. Causes of food-induced anaphylaxis in Italian adults: a multi-centre study. Int Arch Allergy Immunol 2009;150:271277.
  • 21
    Borch JE, Andersen KE, Bindslev-Jensen C. The prevalence of suspected and challenge-verified penicillin allergy in a university hospital population. Basic Clin Pharmacol Toxicol 2006;98:357362.
  • 22
    Bousquet PJ, Kvedariene V, Co-Minh HB, Martins P, Rongier M, Arnoux B et al. Clinical presentation and time course in hypersensitivity reactions to beta-lactams. Allergy 2007;62:872876.
  • 23
    Calvani M, Di Lallo D, Polo A, Spinelli A, Zappala D, Zicari AM. Hospitalizations for pediatric anaphylaxis. Int J Immunopathol Pharmacol 2008;21:977983.
  • 24
    Calvani M, Cardinale F, Martelli A, Muraro A, Pucci N, Savino F et al. Risk factors for severe pediatric food anaphylaxis in Italy. Pediatr Allergy Immunol 2011;22:813819.
  • 25
    Capps JA, Sharma V, Arkwright PD. Prevalence, outcome and pre-hospital management of anaphylaxis by first aiders and paramedical ambulance staff in Manchester. UK. Resuscitation 2010;81:653657.
  • 26
    Celikel S, Karakaya G, Yurtsever N, Sorkun K, Kalyoncu AF. Bee and bee products allergy in Turkish beekeepers: Determination of risk factors for systemic reactions. Allergologia et Immunopathol, 2006;34:180184.
  • 27
    Derby CJ, Gowland MH, Hourihane JO. Sesame allergy in Britain: a questionnaire survey of members of the anaphylaxis campaign. Pediatr Allergy Immunol 2005;16:171175.
  • 28
    Draisci G, Zanfini BA, Nucera E, Catarci S, Sangregorio R, Schiavino D et al. Latex sensitization: a special risk for the obstetric population? Anesthesiology 2011;114:565569.
  • 29
    Gonzalez-Perez A, Aponte Z, Vidaurre CF, Rodriguez LAG. Anaphylaxis epidemiology in patients with and patients without asthma: a united kingdom database review. J Allergy Clin Immunol 2010;125:10981104.
  • 30
    Helbling A, Hurni T, Mueller UR, Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940 000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 2004;34:285290.
  • 31
    Kanny G, Moneret-Vautrin DA, Flabbee J, Beaudouin E, Morisset M, Thevenin F. Population study of food allergy in France. J Allergy Clin Immunol 2001;108:133140.
  • 32
    Lange L, Koningsbruggen SV, Rietschel E. Questionnaire-based survey of lifetime-prevalence and character of allergic drug reactions in German children. Pediatr Allergy Immunol 2008;19:634638.
  • 33
    Laporte JR, de Latorre FJ, Laszlo A, Retsagi G, Gadgil DA, Chandrasekhar DV et al. Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an international study. Pharmacoepidemiol Drug Saf 2003; 12:195202. (International Collaborative Study of Severe Anaphylaxis)
  • 34
    Laxenaire MC, Mertes PM. Groupe d'Etudes des Reactions Anaphylactoides, Peranesthesiques. Anaphylaxis during anaesthesia. results of a two-year survey in France. Br J Anaesth 2001;87:549558.
  • 35
    Nybo M, Madsen JS. Serious anaphylactic reactions due to protamine sulfate: a systematic literature review. Basic Clin Pharmacol Toxicol 2008;103:192196.
  • 36
    Pastorello EA, Rivolta F, Bianchi M, Mauro M, Pravettoni V. Incidence of anaphylaxis in the emergency department of a general hospital in Milan. J Chromatogr B Biomed Sci Appl 2001;756:1117.
  • 37
    Perez Pimiento AJ, Prieto Lastra L, Rodriguez Cabreros MI, Vasquez Bautista AA, Garcia Cubero A, Calvo Manue lE. Systemic reactions to wasp sting: is the clinical pattern related to age, sex and atopy?. [erratum appears in allergol immunopathol (madr). 2007 mar-apr;35(2):51]. Allergol Immunopathol 2007;35:1014.
  • 38
    Quercia O, Incorvaia C, Puccinelli P, Scurati S, Emiliani F, Frati F et al. Prevalence of allergic disorders in Italy: the Cotignola population study. Eur Ann Allergy & ClinImmunol 2012;44:511.
  • 39
    Quiralte J, Blanco C, Delgado J, Ortega N, Alcntara M, Castillo R et al. Challenge-based clinical patterns of 223 Spanish patients with nonsteroidal anti-inflammatory-drug-induced-reactions. J Investig Allergol Clin Immunol 2007;17:182188.
  • 40
    Rance F, Grandmottet X, Grandjean H. Prevalence and main characteristics of schoolchildren diagnosed with food allergies in France. Clin Exp Allergy 2005;35:167172.
  • 41
    Rasmussen TA, Jorgensen MRS, Bjerrum S, Jensen-Fangel S, Stovring H, Ostergaard L et al. Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study. BMJ 2012;345:e5823.
  • 42
    Sandilands EA, Bateman DN. Adverse reactions associated with acetylcysteine. CliniToxicol: Offic J Amer Acad Clin Toxicol & Eur Assoc Poisons Centr & Clin Toxicolo 2009;47:8188.
  • 43
    Sheikh A, Alves B. Hospital admissions for acute anaphylaxis: time trend study. BMJ 2000;320:1441.
  • 44
    van Puijenbroek EP, Egberts ACG, Meyboom RHB, Leufkens HGM. Different risks for NSAID-induced anaphylaxis. Ann Pharmacother 2002;36:2429.
  • 45
    Vetander M, Helander D, Flodstrom C, Ostblom E, Alfven T, Ly DH et al. Anaphylaxis and reactions to foods in children - a population-based case study of emergency department visits. Clin Exp Allergy 2012;42:568577.
  • 46
    Worm M, Edenharter G, Rueff F, Scherer K, Pfohler C, Mahler V et al. Symptom profile and risk factors of anaphylaxis in central Europe. Allergy 2012;67:691698.
  • 47
    Ayala F, Fabbrocini G, Bartiromo F, Barberio E, Rescigno O, Di Simone L et al. Adverse drug reactions: dermatological experience. G Ital di Dermatol Venereol 2006;141:1720.
  • 48
    Dietrich W, Ebell A, Busley R, Boulesteix A. Aprotinin and anaphylaxis: analysis of 12,403 exposures to aprotinin in cardiac surgery. Ann Thorac Surg 2007;84:11441150.
  • 49
    Gibbison B, Sheikh A, McShane P, Haddow C, Soar J. Anaphylaxis admissions to UK critical care units between 2005 and 2009. Anaesthesia 2012;67:833838.
  • 50
    Gupta R, Sheikh A, Strachan D, Anderson HR. Increasing hospital admissions for systemic allergic disorders in England: analysis of national admissions data. BMJ 2003;327:11421143.
  • 51
    Gupta R, Sheikh A, Strachan DP, Anderson HR. Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy 2004;34:520526.
  • 52
    Hopf Y, Watson M, Williams D. Adverse-drug-reaction related admissions to a hospital in Scotland. Pharm World Sci 2008;30:854862.
  • 53
    Mertes PM, Laxenaire M, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003;99:536545.
  • 54
    Mertes PM, Alla F, Trechot P, Auroy Y, Jougla E. Groupe d'Etudes des Reactions Anaphylactoides, Peranesthesiques. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy & Clin Immunol 2011;128:366373.
  • 55
    Sheikh A, Alves B. Age, sex, geographical and socio-economic variations in admissions for anaphylaxis: analysis of four years of English hospital data. Clin Exp Allergy 2001;31:15711576.
  • 56
    Sheikh A, Hippisley-Cox JJ, Newton J, Fenty J. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med 2008;101:139143.
  • 57
    Tejedor Alonso MA, Moro Moro M, Mugica Garcia MV, Esteban Hernandez J, Rosado Ingelmo A, Vila Albelda C et al. Incidence of anaphylaxis in the city of Alcorcon (Spain): a population-based study. Clin Exp Allergy 2012; 42:578589.
    Direct Link:
  • 58
    Tejedor Alonso MA, Moro MM, Hernandez JE, Mugica Garcia MV, Albelda CV, Ingelmo AR et al. Incidence of anaphylaxis in hospitalized patients. Int Arch Allergy Immunol. 2011; 156:212220.
  • 59
    Pakravan N, Waring WS, Sharma S, Ludlam C, Megson I, Bateman DN. Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose. Clin Toxicol: Offic J Amer Acad Clin Toxicol & Eur Assoc Poisons Cent & Clin Toxicolo 2008;46:697702.
  • 60
    Waring WS, Stephen AF, Robinson OD, Dow MA, Pettie JM. Lower incidence of anaphylactoid reactions to N-acetylcysteine in patients with high acetaminophen concentrations after overdose. Clin Toxicol 2008;46:496500.
  • 61
    Moneret-Vautrin DA, Kanny G, Parisot L. Serious food allergy-related accidents in France: frequency, clinical and etiological characteristics. First enquiry carried out by the French ‘allergovigilance network’. [French] Accidents graves par allergie alimentaire en france: frequence, caracteristiques cliniques et etiologiques. Premiere enquete du reseau d'allergovigilance, avril-mai 2001. Revue Francaise d'Allergologie et d'Immunologie Clinique 2001;41:696700.
  • 62
    Michalska-Krzanowska G, Kurek M, Ratajski R. The incidence of anaphylactic reactions in 3560 patients undergoing TIVA with propofol, fentanyl and different neuromuscular blocking agents: a one-year retrospective study. Anestezjologia Intensywna Terapia 2006;38:125128.
  • 63
    Mulier S, Hanssens L, Chaouat P, Casimir G. [Child food allergy: Results of a Belgian cohort]. [French] L'allergie alimentaire chez l'enfant: etude d'une cohorte belge. Rev Med Brux 2006; 27 Spec No:Sp 8286.
  • 64
    Rymarczyk B, Gluck J, Jozwiak P, Rogala B. Incidence and variety of clinical manifestation of food hypersensitivity in the population of Silesia - A questionnaire based study. [Polish]Czestosc wystepowania i charakterystyka reakcji nadwrazliwosci na pokarmy w populacji Slaskiej - Badanie ankietowe. Alergia Astma Immunol 2009;14:248251.
  • 65
    Couto M, de Almeida MM. Allergic disease diagnosis in Portugal: an exploratory study. Diagnostico da doenca alergica em Portugal: um estudo exploratorio. Revista Portuguesa de Imunoalergol 2011; 19:2332.
  • 66
    Branellec A, Thomas M, Fain O, Kettaneh A, Stirnemann J, Letellier E. Frequency of self-reported penicillin allergy in the area of Seine-Saint-Denis(France). Rev Med Interne 2008;29:271276.
  • 67
    Lynch RM, Robertson R. Anaphylactoid reactions to intravenous N-acetylcysteine: a prospective case controlled study. Accid Emerg Nurs 2004;12:1015.
  • 68
    Cetinkaya F, Incioglu A, Birinci S, Karaman BE, Dokucu AI, Sheikh A. Hospital admissions for anaphylaxis in Istanbul. Turkey. Allergy 2013;68:128130.
  • 69
    Worm M. Epidemiology of anaphylaxis. Ring J (ed): Anaphylaxis. Chem Immunol Allergy. Basel, Karger, 2010, vol 95, pp 1221.
  • 70
    Worm M, Hompes S, Vogel N, Kirschbaum J, Zuberbier T. Care of anaphylaxis among practising doctors. Allergy 2008;63:15621563.
  • 71
    Akeson N, Worth A, Sheikh A. The psychosocial impact of anaphylaxis on young people and their parents. Clin Exp Allergy 2007;37:12131220.
  • 72
    Anandan C, Simpson CR, Fischbacher C, Sheikh A. Exploiting the potential of routine data to better understand the disease burden posed by allergic disorders. Clin Exp Allergy 2006;36:866871.
  • 73
    Clark S, Camargo CA. Epidemiology of anaphylaxis. Immunol Allergy Clin N Am 2007;27:145163.